Miao Xiaoping, Chen Tianao, Lang Zhongliang, Wu Yongqi, Wu Xizhi, Zhu Zhiqiang, Xu Ronald X
School of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
Suzhou Institute for Advanced Research, University of Science and Technology of China, Suzhou, Jiangsu, 215123, P. R. China.
J Mater Chem B. 2025 Jan 22;13(4):1252-1269. doi: 10.1039/d4tb02047b.
Vascularization is a critical component of tissue engineering research and is essential for enhancing the success rate of tissue construction and function. Over the past decade, researchers have explored various methods to construct vascular networks, including 3D printing, cell sphere technology, and microfluidics. Microfluidic technology has garnered significant attention due to its notable advantages in precision, controllability, flexibility, and applicability. It can be primarily classified into two modes: (i) the pre-designed mode, which involves creating vascular networks by pre-designing vascular channels and seeding endothelial cells, encompassing microfluidic chips and microfluidic spinning technologies; and (ii) the self-assembly mode, where cell spheres are fabricated using microfluidic technology and subsequently self-assemble into vascular networks. In this review, we first provide a brief overview of the normal physiological and pathological characteristics of vascular networks, followed by a discussion of the factors to be considered in designing vascular networks, and conclude with an examination of the classification of technologies for the preparation of microfluidic vascular networks and recent advancements. It is anticipated that vascular network models will soon be successfully applied in regenerative medicine and drug development.
血管化是组织工程研究的关键组成部分,对于提高组织构建和功能的成功率至关重要。在过去十年中,研究人员探索了多种构建血管网络的方法,包括3D打印、细胞球技术和微流控技术。微流控技术因其在精度、可控性、灵活性和适用性方面的显著优势而备受关注。它主要可分为两种模式:(i)预设计模式,即通过预先设计血管通道并接种内皮细胞来创建血管网络,包括微流控芯片和微流控纺丝技术;(ii)自组装模式,即利用微流控技术制造细胞球,随后细胞球自组装成血管网络。在本综述中,我们首先简要概述血管网络的正常生理和病理特征,接着讨论设计血管网络时需考虑的因素,最后考察微流控血管网络制备技术的分类及最新进展。预计血管网络模型很快将成功应用于再生医学和药物开发。